Preliminary evaluation of a cervical self-sampling device with liquid-based cytology and multiparameter molecular testing

Bradley W. Knesel, Joel C. Dry, Coridalia Wald-Scott, Asma S Aftab

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

OBJECTIVE: To compare the collection of a liquid-based cell sample using a cervical self-sampling device and traditional sampling using cytologic and molecular-based tests. STUDY DESIGN: This study evaluated the sampling efficiency of the Fournier Cervical Self-Sampling Device (BPG, LLC, Miami, Florida) with regard to overall cell volume of the sample, cytologic diagnoses (SurePath, TriPath Imaging, Burlington, North Carolina) and molecular-based tests for Chlamydia, Gonorrhoeae and human papillomavirus (Hybrid Capture 2, Digene Corp., Gaithersburg, Maryland). Paired samples were blinded and prepared using the SurePath method. RESULTS: The self-collected samples showed an overall increase in cellularity when compared to the cellularity of samples obtained from traditional sampling. Cytologic results were comparable for the 2 sampling methods. The self-sampling device showed greater sensitivity with regard to molecular-based human papillomavirus testing. CONCLUSION: The Fournier Device shows promise in the area of cytology and molecular diagnostics. The ability to perform cytology and molecular-based assays using a single sample obtained directly by the patient can lower the costs of screening and provide an efficient method of screening women in resource-poor countries or when cultural barriers exist to the use of traditional sampling methods.

Original languageEnglish
Pages (from-to)256-260
Number of pages5
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume50
Issue number4
StatePublished - Apr 1 2005

Fingerprint

Cell Biology
Equipment and Supplies
Sampling Studies
Molecular Pathology
Chlamydia
Gonorrhea
Cell Size
Costs and Cost Analysis

Keywords

  • Cervical cancer
  • Cervical self-sampling
  • Cervix neoplasms
  • Liquid-based cytology

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Preliminary evaluation of a cervical self-sampling device with liquid-based cytology and multiparameter molecular testing. / Knesel, Bradley W.; Dry, Joel C.; Wald-Scott, Coridalia; Aftab, Asma S.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 50, No. 4, 01.04.2005, p. 256-260.

Research output: Contribution to journalArticle

@article{c16a326f79de4f1f9123d13ea9c19304,
title = "Preliminary evaluation of a cervical self-sampling device with liquid-based cytology and multiparameter molecular testing",
abstract = "OBJECTIVE: To compare the collection of a liquid-based cell sample using a cervical self-sampling device and traditional sampling using cytologic and molecular-based tests. STUDY DESIGN: This study evaluated the sampling efficiency of the Fournier Cervical Self-Sampling Device (BPG, LLC, Miami, Florida) with regard to overall cell volume of the sample, cytologic diagnoses (SurePath, TriPath Imaging, Burlington, North Carolina) and molecular-based tests for Chlamydia, Gonorrhoeae and human papillomavirus (Hybrid Capture 2, Digene Corp., Gaithersburg, Maryland). Paired samples were blinded and prepared using the SurePath method. RESULTS: The self-collected samples showed an overall increase in cellularity when compared to the cellularity of samples obtained from traditional sampling. Cytologic results were comparable for the 2 sampling methods. The self-sampling device showed greater sensitivity with regard to molecular-based human papillomavirus testing. CONCLUSION: The Fournier Device shows promise in the area of cytology and molecular diagnostics. The ability to perform cytology and molecular-based assays using a single sample obtained directly by the patient can lower the costs of screening and provide an efficient method of screening women in resource-poor countries or when cultural barriers exist to the use of traditional sampling methods.",
keywords = "Cervical cancer, Cervical self-sampling, Cervix neoplasms, Liquid-based cytology",
author = "Knesel, {Bradley W.} and Dry, {Joel C.} and Coridalia Wald-Scott and Aftab, {Asma S}",
year = "2005",
month = "4",
day = "1",
language = "English",
volume = "50",
pages = "256--260",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "4",

}

TY - JOUR

T1 - Preliminary evaluation of a cervical self-sampling device with liquid-based cytology and multiparameter molecular testing

AU - Knesel, Bradley W.

AU - Dry, Joel C.

AU - Wald-Scott, Coridalia

AU - Aftab, Asma S

PY - 2005/4/1

Y1 - 2005/4/1

N2 - OBJECTIVE: To compare the collection of a liquid-based cell sample using a cervical self-sampling device and traditional sampling using cytologic and molecular-based tests. STUDY DESIGN: This study evaluated the sampling efficiency of the Fournier Cervical Self-Sampling Device (BPG, LLC, Miami, Florida) with regard to overall cell volume of the sample, cytologic diagnoses (SurePath, TriPath Imaging, Burlington, North Carolina) and molecular-based tests for Chlamydia, Gonorrhoeae and human papillomavirus (Hybrid Capture 2, Digene Corp., Gaithersburg, Maryland). Paired samples were blinded and prepared using the SurePath method. RESULTS: The self-collected samples showed an overall increase in cellularity when compared to the cellularity of samples obtained from traditional sampling. Cytologic results were comparable for the 2 sampling methods. The self-sampling device showed greater sensitivity with regard to molecular-based human papillomavirus testing. CONCLUSION: The Fournier Device shows promise in the area of cytology and molecular diagnostics. The ability to perform cytology and molecular-based assays using a single sample obtained directly by the patient can lower the costs of screening and provide an efficient method of screening women in resource-poor countries or when cultural barriers exist to the use of traditional sampling methods.

AB - OBJECTIVE: To compare the collection of a liquid-based cell sample using a cervical self-sampling device and traditional sampling using cytologic and molecular-based tests. STUDY DESIGN: This study evaluated the sampling efficiency of the Fournier Cervical Self-Sampling Device (BPG, LLC, Miami, Florida) with regard to overall cell volume of the sample, cytologic diagnoses (SurePath, TriPath Imaging, Burlington, North Carolina) and molecular-based tests for Chlamydia, Gonorrhoeae and human papillomavirus (Hybrid Capture 2, Digene Corp., Gaithersburg, Maryland). Paired samples were blinded and prepared using the SurePath method. RESULTS: The self-collected samples showed an overall increase in cellularity when compared to the cellularity of samples obtained from traditional sampling. Cytologic results were comparable for the 2 sampling methods. The self-sampling device showed greater sensitivity with regard to molecular-based human papillomavirus testing. CONCLUSION: The Fournier Device shows promise in the area of cytology and molecular diagnostics. The ability to perform cytology and molecular-based assays using a single sample obtained directly by the patient can lower the costs of screening and provide an efficient method of screening women in resource-poor countries or when cultural barriers exist to the use of traditional sampling methods.

KW - Cervical cancer

KW - Cervical self-sampling

KW - Cervix neoplasms

KW - Liquid-based cytology

UR - http://www.scopus.com/inward/record.url?scp=17644372037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17644372037&partnerID=8YFLogxK

M3 - Article

C2 - 15916209

AN - SCOPUS:17644372037

VL - 50

SP - 256

EP - 260

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 4

ER -